多效蛋白在大肠癌恶性化过程中的作用

目的了解多效蛋白在大肠癌中的表达情况 ,以及对大肠癌恶性化的影响。方法采用RT PCR和免疫组化染色 ,对 2 4例大肠癌组织和 19例大肠癌癌旁组织的多效蛋白mRNA表达情况进行分析。结果 2 4例大肠癌组织和 19例癌旁正常组织中表达多效蛋白mRNA的各有 18例。多效蛋白不但表达在肿瘤细胞 ,还表达在其他间质细胞中。大肠癌组织中多效蛋白的表达明显高于癌旁正常组织 (34%vs.9% ,P <0 0 5 )。 (94 % )大肠癌多效蛋白mRNA主要由内源性多效蛋白转录 ,且表达在肿瘤的 4个分期中 ,而人类内源性逆转录病毒 多效蛋白仅融合转录在Ⅲ、Ⅳ期肿瘤上 (31% )。结论多效蛋白尤其是人类内源性逆转录病毒 多效蛋白与大肠癌的恶性化有关。     

抗CD25抗体预防移植物抗宿主病在儿童白血病半匹配骨髓移植中的应用

目的　探讨抗 CD2 5抗体用于预防儿童白血病半匹配未去 T细胞骨髓移植重度移植物抗宿主病 (GVHD)的疗效。　方法　 10例儿童白血病患者接受 HL A2 - 3位点不合半匹配骨髓移植 ,移植方法除了供者应用粒细胞集落刺激因子 (GCSF)2 5 0μg促进骨髓及受者应用环孢素 A(CSA ) ,甲氨蝶呤 (MTX) ,抗胸腺细胞球蛋白 (ATG)和霉酚酸酯 (MMF)预防 GVHD综合措施外 ,加用抗 CD2 5单克隆抗体预防 GVHD,剂量各为 2 0 m g,在移植前 2 h和移植后第 4天应用 ,采髓后未去 T细胞输注 ,移植结果与前期未用 Simulect移植组比较。　结果　 10例移植后均获造血重建 ,粒细胞大于 0 .5× 10 9/ L 中位天数是19 d,血小板大于 2 0× 10 9/ L 的中位天数是 2 2 d,骨髓植活直接证据检测证实为完全供者造血。无 1例发生急性 ～ GVHD,未用 Sim ulect对照组急性 ～ GVHD为 5 0 % ,差异有显著性意义。可评价慢性 GVHD的 8例均发生慢性 GVHD,均为局限性慢性 GVHD。中位随访 12个月 (范围 9～ 2 4个月 ) ,2例移植相关死亡 ,1例移植后 14个月复发死亡 ,实际无病生存率是 70 % ,与对照比较差异无显著性意义。　结论　本研究儿童半匹配未去 T细胞骨髓移植应用 Sim ulect,明显降低急性重症 a GVHD发生 ,减少移植相关死亡 ,临床应用安全可行。     

The Dynamics of Leaving and Recovering from an Abusive Relationship

The process of leaving an abusive relationship involves repeated attempts at leaving and returning and is influenced by a number of individual characteristics and contextual factors. Leaving is an initial step in recovering from an abusive relationship, a process that also includes struggling for survival, grieving, and searching for the meaning of the experience. Nurses must recognize that recovering from an abusive relationship can be a lifelong process, and health care providers have unique opportunities to support a woman's recovery.     

BDNF基因修饰神经干细胞移植后大鼠脊髓损伤移植处的基因表达变化

目的：了解脑源性神经营养因子（Brain-derived neurotrophic factor,BDNF）基因修饰神经干细胞移植到大鼠脊髓损伤处后的基因表达变化，为脊髓损伤修复提供基础研究资料。方法：大鼠随机分为4组：正常对照组，手术对照组，神经干细胞（Neural stem cells,NSCs）移植组，BDNF－NSCs移植组，各组分4个时相点（7d、1个月、2个月、3个月），利用细胞移植、X-gal组化、免疫组化、原位杂交等方法，观察了移植处细胞的标记基因（LacZ）表达和BDNF、胶质纤维酸性蛋白（GFAP）、神经丝－200（NF－200）的表达。结果：大鼠脊髓损伤移植处细胞中，有标记基因阳性细胞，BDNF强烈表达，尤其是BDNF－NSCs移植组的移植后1周和1个月时。各组各时相点均有GFAP和NF－200免疫反应阳性细胞和纤维。结论：BDNF基因修饰神经干细胞能在脊髓损伤移植处存活，强烈表达BDNF，BDNF基因修饰神经干细胞可以作为脊髓损伤修复的移植材料。     

丙泊酚、硫喷妥钠联合麻醉诱导对血液动力学的影响

目的：观察小剂量丙泊酚和硫喷妥钠联合用于麻醉诱导对血流动力学的影响及临床应用价值。方法：择期全身麻醉气管插管手术患者84例，ASAⅠ-Ⅱ级，随机分成3组（n=28），硫喷妥钠组（A组）：诱导量5mg/kg；丙泊酚组（B组）；诱导量2.0mg/kg；联合诱导组（C组）硫喷妥钠1－2mg/kg加丙泊酚0.5-1.0mg/kg，观察诱导后2min,5min,10min血液动力学变化。结果：C组在丙泊酚诱导前先静脉预注硫喷妥钠1－2mg/kg，患者静脉注射部位疼痛发生率明显低于B组（P＜0．01），平均动脉压和心率均无明显变化（P＞0．05），而A和B组给药后2min与5min平均动脉压均低于麻醉前，心率均高于麻醉前（P＜0．05－P＜0．05）。结论：丙泊酚与硫喷妥钠联合麻醉诱导具有协同作用，减少单独用药不良反应发生率，血液动力学稳定，麻醉诱导更加平稳，安全，为临床全麻诱导提供一种可行的方法。     

Milgram and Tuskegee—Paradigm Research Projects in Bioethics

This paper discusses the use of the Milgram obedience experiments and the Tuskegee syphilis study in the bioethical literature. The two studies are presented and a variety of uses of them identified and discussed. It is argued that the use of these studies as paradigms of problematic research relies on a reduction of their complexity. What is discussed is thus often constructions of these studies that are closer to hypothetical examples than to the real studies.     

人心肌肌钙蛋白T的提取、纯化及鉴定研究

目的 :探究一种简便易行的人心肌肌钙蛋白T(cTnT)的提纯方法并进行鉴定。　方法 :采用匀浆、离心、70℃加热、冰浴、饱和硫酸铵盐析、透析、DEAE 纤维素层析等方法提纯cTnT ,并进行鉴定和免疫活性检测。　结果 :1 0 0g心肌组织中获得cTnT 2 1 .35 6mg ,纯度最高达 91 .7%。　结论 :建立的方法能成功提取纯度较高 ,且具有免疫活性的人心肌cTnT ,为建立适用于临床的cTnT检测方法奠定基础     

踝关节慢性前外侧不稳的手术治疗

目的: 探讨治疗踝关节慢性前外侧不稳定 (踝关节外侧不稳定合并距下关节不稳定) 的合理而有效的手术方式。方法: 自 1999 ~2003年, 应用Chrisman Snook术式, 以腓骨短肌腱前半部分重建距腓前韧带、跟腓韧带和距跟外侧韧带,治疗踝关节慢性前外侧不稳 8例患者,共 13例关节。结果: 术后随诊 6个月~5年, 平均 19个月。术后所有踝关节均达到功能稳定, 关节活动度基本恢复正常, 没有复发性踝关节不稳发生。以Good评级标准作为疗效评价, 10例关节 (77% ) 为优, 2例关节 (15% ) 为良, 1例关节为中 (7% ), 优良率达 92%。结论: Chrisman Snook术式重建了距腓前韧带、跟腓韧带和距跟外侧韧带, 有效地矫正了踝关节外侧不稳定和距下关节不稳定, 是治疗踝关节慢性前外侧严重不稳定的合理而有效的治疗方法。     

Select types of supporting cell in the inner ear express aquaporin-4 water channel protein

Aquaporins (AQPs) confer a high water permeability on cell membranes and play important parts in secretory and absorptive epithelia in kidney and other organs. Here we investigate whether AQPs are expressed in the sensory epithelia of the inner ear, where a precise volume regulation is crucial. By use of specific antibodies it was found that the inner ear contains AQP1 and 4 while being devoid of detectable levels of AQP2, 3 or 5. Immunofluorescence and postembedding immunogold labelling revealed a strictly non-epithelial distribution of AQP1, confirming previous data. In contrast, AQP4 protein and mRNA (visualized by in situ hybridization) were concentrated in select types of supporting cell, including Hensen's cells and inner sulcus cells. Immunogold particles signalling AQP4 were confined to the basolateral plasma membrane of Hensen's cells and to the basal plasma membrane of Claudius cells and inner sulcus cells. AQP4 was also found in supporting cells of the vestibular end organs, but was absent from transitional epithelial cells and dark cells. Strong labelling for AQP4 and AQP4-mRNA was associated with the central part of the cochlear and vestibular nerves. Hair cells were consistently unlabelled. Our findings indicate that AQP4 may facilitate osmotically driven water fluxes in the sensory epithelia of the inner ear and thus contribute to the volume and ion homeostasis at these sites.